SCHEMBL20465321

SCHEMBL20465321

c1ccc2c(c1)oc1c3ccc(-c4ccc5c(c4)c4cccc6c7ccccc7n5c64)cc3c3ccccc3c21

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.35
PLA2G2A P14555 4/20 0.34
PLA2G4A P47712 4/20 0.34
PLA2G10 O15496 1/20 0.34
PRKDC P78527 1/20 0.31
ALDH1A1 P00352 2/20 0.31
KDM4E B2RXH2 2/20 0.31
MEN1 O00255 2/20 0.31
MAPT P10636 2/20 0.31
HPGD P15428 2/20 0.31
KMT2A Q03164 2/20 0.31
POLB P06746 1/20 0.31
HTT P42858 1/20 0.31
NPSR1 Q6W5P4 1/20 0.30
RXFP1 Q9HBX9 1/20 0.30
CYP3A4 P08684 1/20 0.30
ALPI P09923 1/20 0.30
GAA P10253 1/20 0.30
PKM P14618 1/20 0.30
CASP3 P42574 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26286860 0.89 PLA2G2A (0.35) PLA2G2APLA2G4APLA2G10ALDH1A1KDM4E
SCHEMBL26286319 0.89 PLA2G2A (0.35) PLA2G2APLA2G4APLA2G10ALDH1A1KDM4E
SCHEMBL26286833 0.86 PLA2G2A (0.39) PLA2G2APLA2G4APLA2G10PRKDCALDH1A1
SCHEMBL26286244 0.84 PLA2G2A (0.33) PLA2G2APLA2G4APLA2G10ALDH1A1KDM4E
SCHEMBL26286731 0.83 PLA2G2A (0.34) ALOX5PLA2G2APLA2G4APLA2G10PRKDC
SCHEMBL26286525 0.83 PLA2G2A (0.36) PLA2G2APLA2G4APLA2G10PRKDC
SCHEMBL21453754 0.83 AHR (0.41) ALOX5PLA2G2APLA2G4APLA2G10PRKDC
SCHEMBL26286219 0.83 ALOX5 (0.38) ALOX5PLA2G2APLA2G4APLA2G10PRKDC
SCHEMBL21453580 0.83 KDM4E (0.41) ALDH1A1KDM4EMEN1MAPTHPGD
SCHEMBL22858117 0.83 KDM4E (0.41) ALDH1A1KDM4EMEN1MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11512086-B2 Compound for organic electrical element, organic electrical element using compound, and electronic device therefor DUK SAN NEOLUX CO., LTD. (KR) 2022-11-29 US disclosed
US-20180222910-A1 COMPOUND FOR ORGANIC ELECTRICAL ELEMENT, ORGANIC ELECTRICAL ELEMENT USING COMPOUND, AND ELECTRONIC DEVICE THEREFOR DUK SAN NEOLUX CO., LTD. (KR) 2018-08-09 US disclosed
US-20180222910-A1 COMPOUND FOR ORGANIC ELECTRICAL ELEMENT, ORGANIC ELECTRICAL ELEMENT USING COMPOUND, AND ELECTRONIC DEVICE THEREFOR DUK SAN NEOLUX CO., LTD. (KR) 2018-08-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180222910-A1 COMPOUND FOR ORGANIC ELECTRICAL ELEMENT, ORGANIC ELECTRICAL ELEMENT USING COMPOUND, AND ELECTRONIC DEVICE THEREFOR OR51E2, WEE1, SLC39A11 ALOX5 800/4885PLA2G2A 4314/4885PLA2G4A 4491/4885
US-11512086-B2 Compound for organic electrical element, organic electrical element using compound, and electronic device therefor OR51E2, WEE1, SLC39A11 ALOX5 800/4885PLA2G2A 4314/4885PLA2G4A 4491/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.